Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
Department of Small Animal Medicine and Surgery
College of Veterinary Medicine
University of Georgia
Athens, GA 30602
|
Pimobendan treatment in dogs with congestive heart failure
November 1, 2007
By:
Justin D. Thomason, DVM, DACVIM (small animal internal medicine)
,
Tiffany L. Fallaw, BS, RVT
,
Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
Editors' note: This article is an updated excerpt from "Pimobendan: Understanding its cardiac effects in dogs with myocardial disease," which appeared in Veterinary Medicine's October 2006 issue.
|
Hyperlipidemia in dogs and cats
September 1, 2007
By:
Justin D. Thomason, DVM, DACVIM (small animal internal medicine)
,
Bente Flatland, DVM, DACVIM (internal medicine)
,
Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
Hyperlipidemia is the increased concentration of triglyceride (hypertriglyceridemia), cholesterol (hypercholesterolemia), or both in the blood.
|
Pimobendan: Understanding its cardiac effects in dogs with myocardial disease
October 1, 2006
By:
Justin D. Thomason, DVM, DACVIM (small animal internal medicine)
,
Tiffany L. Fallaw, BS, RVT
,
Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
Pimobendan, a benzimidazole-pyridazinone drug, is classified as an inodilator because of its nonsympathomimetic, nonglycoside positive inotropic (through myocardial calcium sensitization) and vasodilator properties.
|
The pathophysiology of DIC: When the hemostatic system malfunctions
September 1, 2005
By:
Justin D. Thomason, DVM, DACVIM (small animal internal medicine)
,
Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
,
Craig E. Greene, DVM, MS, DACVIM
Disseminated intravascular coagulation (DIC), also known as consumptive coagulopathy or defibrination syndrome, is an acquired disorder of the hemostatic system that results in the pathologic activation and disequilibria of normal hemostasis and fibrinolysis, leading to potentially fatal consequences. This syndrome is common in critically ill veterinary patients and is always secondary to an underlying disorder that increases systemic thrombin and plasmin activities.
|
DIC: Diagnosing and treating a complex disorder
September 1, 2005
By:
Justin D. Thomason, DVM, DACVIM (small animal internal medicine)
,
Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
,
Craig E. Greene, DVM, MS, DACVIM
In this article, we provide guidance to help you identify and effectively treat patients with DIC early, improving their outcome.
|
|